TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: PAUC(test)/PAUC(reference) ratios for PAUC0‐3 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAUC(test)/PAUC(reference) ratios for PAUC3‐24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New ischemic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Persistent virologic remission (PVR)
Endpoint domain: Mortality/survival
Primary endpoint: HBsAg clearance
Endpoint domain: Mortality/survival
Primary endpoint: Summed pain intensity difference over 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean FA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief from angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean quality-adjusted life years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incremental net monetary benefit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 10-year implant survival rate
Endpoint domain: Mortality/survival
Primary endpoint: 10-year retreatment rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: IIEF-EFD score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: subsequent death rate
Endpoint domain: Mortality/survival
Primary endpoint: mean length of stay in hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood loss 8 h post surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infantile VL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: GPE (Global Perceived Effect)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: virological success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean reduction in log10 HIV‐1 RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean change in CD4 lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in HbA(1c) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in fasting plasma glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of pre-eclampsia
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction with healthcare
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Signs of the inhibited type of reactive attachment disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs of the disinhibited type of reactive attachment disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in transient myocardial ischaemia (TMI) by AECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nitroglycerin consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Forced Expiratory Flow (FEF 25, 50, 75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent increase in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of grade 1 lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative complications (excluding lymphedema)
Endpoint domain: Adverse events/effects
Primary endpoint: device-related thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total anesthesia-related times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: needling time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adaptive behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: choice-making
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: CGI‐I scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression through difficulty levels of Pilates exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: state trait anger
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PA mean pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overjet reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global function above 60
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fasting NEFA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: dental material intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: atopy
Endpoint domain: Adverse events/effects
Primary endpoint: metal allergies
Endpoint domain: Adverse events/effects
Primary endpoint: Cartilage thinning in the trochlea of the femur
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cartilage thickening in the central medial aspect of the femur
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Resolution of posttraumatic bone marrow lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Caries rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pleurodesis success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of fever
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of Intracerebral Hemorrhage (ICH)
Endpoint domain: Mortality/survival
Primary endpoint: Change in step-length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional goal attainment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: probabilities of being disease free at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: time to resume diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precipitated withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen dependency at 36 weeks after conception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of necrotizing enterocolitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Appetite assessment (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Albumin and prealbumin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time for robot setup
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time for accomplishing vas deferens and seminal vesicle dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accumulated survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Urine Na/K ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: loss of tooth or crown
Endpoint domain: Mortality/survival
Primary endpoint: 20-year survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 20-year technical success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decrease in alcohol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of ocular neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: a-wave amplitudes of combined rod-cone response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: b-wave amplitudes of combined rod-cone response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall risk of fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hip fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sero-response against NZ98/254
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: remission frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day mortality rate after surgery
Endpoint domain: Mortality/survival
Primary endpoint: Declines in overall negative reactions to behavior problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ve/Vco(2) slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cost of small‐incision cholecystectomy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost of laparoscopic cholecystectomy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time lost away from work
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Proportion of participants at high risk of developing lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Successful TOV in recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficient between Cmax and AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in terminal hair count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back-specific disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: urinary leakage (pad usage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urethral stricture rate
Endpoint domain: Adverse events/effects
Primary endpoint: Peak Torque Test (PeakTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: relapse-free survival at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: AF-free rate at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean AF burden reduction at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of HIV-infected infants starting inpatient ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median days to ART initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCyR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMR + CMR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rehospitalizations plus unscheduled visits for HF/patient
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in the number of circulating osteoclast precursors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Reduction in osteoclast formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Reduction in levels of pro‐osteoclastogenic cytokines (RANKL, TNF, OPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Awareness of workplace violence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes towards workplace violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-confidence regarding workplace violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: muscle total creatine content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quadriceps muscle CSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Caries-survival
Endpoint domain: Mortality/survival
Primary endpoint: Salivary MS counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbial outcomes
Primary endpoint: median daily decrease in intake of fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median increase in intake of dietary fibre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median increase in intake of fruit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h urinary protein excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of pregnancy complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: legs lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: reduction of depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sex risk behavior
Endpoint domain: Life impact
Endpoint subdomain: Risk behavior
Primary endpoint: Drug risk behavior
Endpoint domain: Life impact
Endpoint subdomain: Risk behavior
Primary endpoint: microvascular responsiveness to ACh
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary glucose excretion (ΔUGE24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: diastolic WSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systolic WSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Timing adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportional memory reduction for negative vs positive images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall accuracy for MS-325-enhanced carotid MR angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alopecia grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: TAA-specific or vaccine-specific immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of outliers for HKA, CFA, and CTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CFA accuracy at 90°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for stapled technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cosmetic score on visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: AQLQ score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Eosinophil counts in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acceptance rate of semiautomated measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in measurements by 2 mm or less
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the curve of Glucagon-like peptide-1 secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: α‐tocopherol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retinol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GSSG content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee injury and Osteoarthritis Outcome Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm Knee Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: World Health Organization Quality of Life-brief version
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: success rate at first insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood staining on the PLMA
Endpoint domain: Adverse events/effects
Primary endpoint: Mean JSW loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement or stabilization of health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain metrics performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of recovery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: quality of recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cognitive function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of bronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4(+) cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of colorectal cancer (CRC)
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in pain at tender points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporal standard deviation of RR segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical global impression of improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BTX‐A effect on one side of the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-perceived reduction in injection discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance with sulphasalazine
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance with physical exercise
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance with energy conservation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance with joint protection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: proportion of breastfeeding at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate post intervention mean knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants answering ≥4/5 questions correctly
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants comfortable taking chlorthalidone if prescribed
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RV end-diastolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: WHO functional class improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement rates of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline rate of WBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bacteriological efficacy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in social support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Modification of self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of barriers to physical activity and diet
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-report measures of anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average platelet levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Median PSA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of anesthesia rated by patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reporting of statistical power calculations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of poisoning-related emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hospital admission rate for poisoning-related visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incidence of peri-operative hypothermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal thermal comfort scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: severe adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of large-for-gestational-age (LGA) newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes